World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
33230
World Ranking
19270
National Ranking
9599

Overview

Keith D. Dawkins is a researcher affiliated with Boston Scientific in the United States. Their work focuses primarily on the field of Medicine with published contributions also found in related subfields such as Surgery, Cardiology and Cardiovascular Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics of Dawkins' research include:

  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics

The researcher has published work in the European Journal of Preventive Cardiology, marking a presence in that specific publication venue.

One notable paper authored by Dawkins is titled "Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization", published in 2020 in the European Journal of Preventive Cardiology with 16 citations to date.

Frequent collaborators in Dawkins' research include:

  • Kuniaki Takahashi
  • Daniel J.F.M. Thuijs
  • Chao Gao
  • Masafumi Ono
  • David R. Holmes

Best Publications

  • Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

    Patrick W. Serruys;Marie-Claude Morice;A. Pieter Kappetein;Antonio Colombo

  • The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

    Sianos G;Morel Ma;Kappetein Ap;Morice Mc

  • Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease : 5-year follow-up of the randomised, clinical SYNTAX trial

    Friedrich W. Mohr;Marie Claude Morice;A. Pieter Kappetein;Ted E. Feldman

  • Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents

    Gregg W. Stone;Jeffrey W. Moses;Stephen G. Ellis;Joachim Schofer

  • Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

    Vasim Farooq;David Van Klaveren;Ewout W. Steyerberg;Emanuele Meliga

  • Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Assessment of the SYNTAX score in the Syntax study

    Patrick W. Serruys;Yoshinobu Onuma;Scot Garg;Giovanna Sarno

  • Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

    Anthony H. Gershlick;Amanda Stephens-Lloyd;Sarah Hughes;Keith R. Abrams

  • Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial

    Arie Pieter Kappetein;Ted E. Feldman;Michael J. MacK;Marie Claude Morice

  • Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.

    Conor M. Burke;James Theodore;Keith D. Dawkins;Samuel A. Yousem

  • Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice

    Keith D. Dawkins;Eberhard Grube;Giulio Guagliumi;Adrian P. Banning

  • Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial

    Arie Pieter Kappetein;Stuart J. Head;Marie-Claude Morice;Adrian P. Banning

  • Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial

    Stuart J. Head;Piroze M. Davierwala;Patrick W. Serruys;Simon R. Redwood

  • Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents

    Adrian P. Banning;Stephen Westaby;Marie-Claude Morice;A. Pieter Kappetein

  • Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery

    David J. Cohen;Ben Van Hout;Patrick W. Serruys;Friedrich W. Mohr

  • Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score

    Vasim Farooq;Patrick W. Serruys;Christos V. Bourantas;Yaojun Zhang

  • A New Tool for the Risk Stratification of Patients With Complex Coronary Artery Disease The Clinical SYNTAX Score

    Scot Garg;Giovanna Sarno;Hector M. Garcia-Garcia;Chrysafios Girasis

  • Cyphering the Complexity of Coronary Artery Disease Using the Syntax Score to Predict Clinical Outcome in Patients With Three-Vessel Lumen Obstruction Undergoing Percutaneous Coronary Intervention

    Marco Valgimigli;Patrick Washington Serruys;Keiichi Tsuchida;Sophia Vaina

Frequent Co-Authors

Patrick W. Serruys
Patrick W. Serruys University of Galway
Antonio Colombo
Antonio Colombo Humanitas Clinical and Research Center IRCCS
Friedrich W. Mohr
Friedrich W. Mohr Leipzig University
Ted Feldman
Ted Feldman Edwards Lifesciences (United States)
David R. Holmes
David R. Holmes Mayo Clinic
Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Eberhard Grube
Eberhard Grube University Hospital Bonn
Stephen G. Ellis
Stephen G. Ellis Cleveland Clinic
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Michael J. Mack
Michael J. Mack Scott & White Memorial Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about alternative pathways to a career in healthcare? Online health and medical degrees are becoming increasingly popular for their flexibility and affordability—perfect for those wanting to study while working or managing other responsibilities.

For students interested in data and technology within healthcare, a health information management degree online can open doors to roles in health data analysis, patient records, and compliance. If you’re looking for quick entry into the field, consider enrolling in one of the cheapest medical billing and coding online courses to start a career in administrative support for clinics and hospitals.

Nursing remains a high-demand field in the USA. Prospective nurse practitioners can access the cheapest np programs online to become trusted advanced practice providers. Registered nurses aiming for leadership and specialized roles might be interested in the cheapest online msn programs to take their qualifications a step further.

These online programs provide accessible, affordable career pathways into the US healthcare system—offering diverse roles beyond traditional medical degrees.

Best Scientists Citing Keith D. Dawkins

Trending Scientists